Cyclohexylamine

Cyclohexylamine

SCHEMBL3501943

NC1CCCCC1.O=S(=O)(O)O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Cyclohexylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
CA1 P00915 3/20 0.39
CA2 P00918 2/20 0.39
EPHX1 P07099 1/20 0.39
MMP1 P03956 1/20 0.36
MMP8 P22894 1/20 0.36
CA12 O43570 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5A P35218 1/20 0.35
CA5B Q9Y2D0 1/20 0.35
THRB P10828 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexylamine SCHEMBL27744924 1.00 ALDH1A1 (0.41) ALDH1A1CA1CA2EPHX1MMP1
Cyclohexylamine SCHEMBL28860745 0.97 ALDH1A1 (0.39) ALDH1A1CA1CA2EPHX1MMP1
Cyclohexylamine SCHEMBL9792266 0.95 ALDH1A1 (0.38) ALDH1A1CA1CA2EPHX1MMP1
Cyclohexylamine SCHEMBL27711124 0.89 CA1 (0.42) ALDH1A1CA1CA2EPHX1MMP1
Cyclooctanamine SCHEMBL521739 0.89 MMP8 (0.42) ALDH1A1CA1CA2EPHX1MMP1
Cyclohexylamine SCHEMBL27416385 0.89 MMP8 (0.42) ALDH1A1CA1CA2EPHX1MMP1
Cyclohexylamine SCHEMBL7357483 0.89 CA1 (0.42) ALDH1A1CA1CA2EPHX1MMP1
SCHEMBL520280 0.89 MMP8 (0.42) ALDH1A1CA1CA2EPHX1MMP1
Sulfuric Acid SCHEMBL28248625 0.87
Cyclopentanamine SCHEMBL19198718 0.87 ALDH1A1 (0.33) ALDH1A1CA1CA2EPHX1MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116650425-A Use of sugar ester compounds or salts thereof in cryoprotection and freeze-drying protection 晟迪生物医药(苏州)有限公司 2023-08-29 CN disclosed
CN-108570021-B Vulcanization accelerator CBS and continuous production method thereof 科迈化工股份有限公司 2022-08-16 CN disclosed
EP-2614733-B1 Glove SHOWA GLOVE CO (JP) 2018-11-14 EP disclosed
CN-108586383-A A kind of continuous production method of accelerator D CBS 科迈化工股份有限公司 2018-09-28 CN disclosed
CN-108570021-A A kind of aniline fluid bed and its continuous production method 科迈化工股份有限公司 2018-09-25 CN disclosed
US-20160369237-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECH INC (US) 2016-12-22 US disclosed
US-20130180028-A1 GLOVE SHOWA GLOVE CO. (JP) 2013-07-18 US disclosed
EP-2614733-A2 Glove SHOWA GLOVE Co. (JP) 2013-07-17 EP disclosed
CN-101245019-B Novel technique for synthesizing quaternary ammonium salt QIU JIANXING 2011-04-20 CN disclosed
US-20100184033-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY Lineage Cell Therapeutics, Inc. 2010-07-22 US disclosed
CN-101245019-A Novel technique for synthesizing quaternary ammonium salt QIU JIANXING (CN) 2008-08-20 CN disclosed
EP-1903873-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS THE UNIVERSITY OF ROCHESTER (US) 2008-04-02 EP disclosed
US-20080070303-A1 Using myocardial and/or muscle progenitor cells as modeling tool in tissue engineering; regenerative medicine and organ replacement ADVANCED CELL TECHNOLOGY 2008-03-20 US disclosed
WO-2007062198-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECHNOLOGY, INC. (US) 2007-05-31 WO disclosed
WO-2006135602-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS UNIVERSITY OF ROCHESTER (US) 2006-12-21 WO disclosed
US-4753736-A USING AQUEOUS SOLUTION OF CITRATE SALT OF VOLATILE AMINE BETZ LABORATORIES, INC. (US) 1988-06-28 US disclosed
US-4663421-A Polyarylate having amide terminal groups GENERAL ELECTRIC COMPANY (US) 1987-05-05 US disclosed
US-4557856-A Electrically conductive composition for electro-responsive recording materials MITA INDUSTRIAL CO., LTD. (JP) 1985-12-10 US disclosed
US-4506064-A HEAT RESISTANT MOLDING MATERIALS GENERAL ELECTRIC COMPANY (US) 1985-03-19 US disclosed
US-4206088-A ACID /ADDITION SALT OF ORGANONITROGEN BASE ABOSRBED ON SOLID INORGANIC ACID MITA INDUSTRIAL COMPANY LIMITED (JP) 1980-06-03 US disclosed